The exact prevalence of GLP-1RA-induced acute pancreatitis remains uncertain but, between 2007 and 2025, the MHRA received 1,296 Yellow Card reports of pancreatitis associated with GLP-1RAs or dual GLP-1/GIPRAs
It plays a central role in lipid, amino acid, glucose metabolism , and mitochondrial energy production , as well as in the synthesis of hemoglobin, neurotransmitters, cholesterol and steroid hormones , and other proteins and lipids
A recent paper published in The Lancet showed that nearly 20% of participants in lifestyle interventions without medications gain weight, around 40% lose between 1-10% of their body weight, and just 13% lose more than 10%
The concern here is: "They are both incretin-related drugs, so is it okay to use them together?" This is the point